国际标准期刊号: 2155-952X

生物技术与生物材料

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 研究圣经
  • 中国知网(CNKI)
  • 访问全球在线农业研究 (AGORA)
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • SWB 在线目录
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

In Vitro Cytotoxicity Testing of Carbon Dot Nanoparticles

Sharath R

Cancer remains as one of the deadliest disease, causing large number of deaths worldwide. The expanding use of cancer immunotherapy has revealed that the survival patients suffer from various serious side effects due to the use of available anti-neoplastic medicines. The development of nanoparticle-based drugs seems to be effective providing low side effects and targeted action on cancer cells. The metal nanoparticles pose some side effects due to their toxicity whereas the Non-metallic Carbon dots (C-dots) are non –toxic and their applications in the field of medicine are less known. In the present study C-dots were synthesized by a simple single step wet chemical method from three different compounds namely Glucose (GCD), Sucrose (SCD) and Fructose (FCD) and characterized with UV-Visible and fluorescence spectroscopic techniques. The C-Dots were screened for the cytotoxicity against two cancer cell lines human Liver carcinoma cells (HepG2) and human breast carcinoma cells (MCF -7) by the MTT assay. The IC50 of the C-dot nanoparticles (SCD, GCD, FCD) on HepG2 cells were 67.24, <50 and and<50 μg/ml respectively and on MCF-7 cells were 105, <50 and <50 μg/ml respectively. The study reveals that the C-dots possess cytotoxic activity against the cancer cell lines and can be further used for the anticancer drug discovery.